207 related articles for article (PubMed ID: 24235289)
1. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function.
Duranton F; Lundin U; Gayrard N; Mischak H; Aparicio M; Mourad G; Daurès JP; Weinberger KM; Argilés A
Clin J Am Soc Nephrol; 2014 Jan; 9(1):37-45. PubMed ID: 24235289
[TBL] [Abstract][Full Text] [Related]
2. Association between Urine Ammonium and Urine TGF-
Raphael KL; Gilligan S; Hostetter TH; Greene T; Beddhu S
Clin J Am Soc Nephrol; 2018 Feb; 13(2):223-230. PubMed ID: 29146699
[TBL] [Abstract][Full Text] [Related]
3. Serum Metabolomic Alterations Associated with Proteinuria in CKD.
Luo S; Coresh J; Tin A; Rebholz CM; Appel LJ; Chen J; Vasan RS; Anderson AH; Feldman HI; Kimmel PL; Waikar SS; Köttgen A; Evans AM; Levey AS; Inker LA; Sarnak MJ; Grams ME;
Clin J Am Soc Nephrol; 2019 Mar; 14(3):342-353. PubMed ID: 30733224
[TBL] [Abstract][Full Text] [Related]
4. Urine and serum midkine levels in an Australian chronic kidney disease clinic population: an observational study.
Campbell VK; Anstey CM; Gately RP; Comeau DC; Clark CJ; Noble EP; Mahadevan K; Hollett PR; Pollock AJ; Hall ST; Jones DR; Burg D; Gray NA
BMJ Open; 2017 Sep; 7(9):e014615. PubMed ID: 28963279
[TBL] [Abstract][Full Text] [Related]
5. Association of urinary excretion rates of uric acid with biomarkers of kidney injury in patients with advanced chronic kidney disease.
López Iglesias A; Blanco Pardo M; Rodríguez Magariños C; Pértega S; Sierra Castro D; García Falcón T; Rodríguez-Carmona A; Pérez Fontán M
PLoS One; 2024; 19(6):e0304105. PubMed ID: 38861521
[TBL] [Abstract][Full Text] [Related]
6. Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics.
Gagnebin Y; Jaques DA; Rudaz S; de Seigneux S; Boccard J; Ponte B
Sci Rep; 2020 Nov; 10(1):19502. PubMed ID: 33177589
[TBL] [Abstract][Full Text] [Related]
7. Revealing novel biomarkers for diagnosing chronic kidney disease in pediatric patients.
Benito S; Unceta N; Maciejczyk M; Sánchez-Ortega A; Taranta-Janusz K; Szulimowska J; Zalewska A; Andrade F; Gómez-Caballero A; Dubiela P; Barrio RJ
Sci Rep; 2024 May; 14(1):11549. PubMed ID: 38773318
[TBL] [Abstract][Full Text] [Related]
8. Impaired Tubular Secretion of Organic Solutes in Advanced Chronic Kidney Disease.
Mair RD; Lee S; Plummer NS; Sirich TL; Meyer TW
J Am Soc Nephrol; 2021 Nov; 32(11):2877-2884. PubMed ID: 34408065
[TBL] [Abstract][Full Text] [Related]
9. Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach.
Gajjala PR; Bruck H; Noels H; Heinze G; Ceccarelli F; Kribben A; Saez-Rodriguez J; Marx N; Zidek W; Jankowski J; Jankowski V
J Mol Med (Berl); 2019 Oct; 97(10):1451-1463. PubMed ID: 31385015
[TBL] [Abstract][Full Text] [Related]
10. A combined epidemiologic and metabolomic approach improves CKD prediction.
Rhee EP; Clish CB; Ghorbani A; Larson MG; Elmariah S; McCabe E; Yang Q; Cheng S; Pierce K; Deik A; Souza AL; Farrell L; Domos C; Yeh RW; Palacios I; Rosenfield K; Vasan RS; Florez JC; Wang TJ; Fox CS; Gerszten RE
J Am Soc Nephrol; 2013 Jul; 24(8):1330-8. PubMed ID: 23687356
[TBL] [Abstract][Full Text] [Related]
11. Validation of Surrogates of Urine Osmolality in Population Studies.
Youhanna S; Bankir L; Jungers P; Porteous D; Polasek O; Bochud M; Hayward C; Devuyst O
Am J Nephrol; 2017; 46(1):26-36. PubMed ID: 28586769
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel biomarkers for frailty diagnosis via serum amino acids metabolomic analysis using UPLC-MS/MS.
Zhou M; Sun W; Chu J; Liao Y; Xu P; Chen X; Li M
Proteomics Clin Appl; 2024 May; 18(3):e2300035. PubMed ID: 38196151
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients.
Hallan S; Afkarian M; Zelnick LR; Kestenbaum B; Sharma S; Saito R; Darshi M; Barding G; Raftery D; Ju W; Kretzler M; Sharma K; de Boer IH
EBioMedicine; 2017 Dec; 26():68-77. PubMed ID: 29128444
[TBL] [Abstract][Full Text] [Related]
14.
Luo S; Surapaneni A; Zheng Z; Rhee EP; Coresh J; Hung AM; Nadkarni GN; Yu B; Boerwinkle E; Tin A; Arking DE; Steinbrenner I; Schlosser P; Köttgen A; Grams ME
Clin J Am Soc Nephrol; 2020 Dec; 16(1):37-47. PubMed ID: 33380473
[TBL] [Abstract][Full Text] [Related]
15. Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome.
Rysz J; Gluba-Brzózka A; Franczyk B; Jabłonowski Z; Ciałkowska-Rysz A
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28777303
[TBL] [Abstract][Full Text] [Related]
16. Metabolite Profiling of Feces and Serum in Hemodialysis Patients and the Effect of Medicinal Charcoal Tablets.
Liu S; Liang S; Liu H; Chen L; Sun L; Wei M; Jiang H; Wang J
Kidney Blood Press Res; 2018; 43(3):755-767. PubMed ID: 29804117
[TBL] [Abstract][Full Text] [Related]
17. Metabolic implications of amino acid metabolites in chronic kidney disease progression: a metabolomics analysis using OPLS-DA and MBRole2.0 database.
Kang J; Guo X; Peng H; Deng Y; Lai J; Tang L; Aoieong C; Tou T; Tsai T; Liu X
Int Urol Nephrol; 2024 Mar; 56(3):1173-1184. PubMed ID: 37728808
[TBL] [Abstract][Full Text] [Related]
18. Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function management.
Assis RP; Castro JF; Gutierres VO; Arcaro CA; Brotto RS; Oliveira OM; Baviera AM; Brunetti IL
BMC Nephrol; 2015 Apr; 16():50. PubMed ID: 25886160
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel serum metabolic signatures to predict chronic kidney disease among Chinese elders using UPLC-Orbitrap-MS.
Liu Y; Sun M; Sun J; Lin F; Xu D; Chen Y; Song W; Li Q; Jiang Y; Gu J; Li S; Gu L; Zhu X; Fang J; Chen M; Chen W
J Nutr Health Aging; 2024 Mar; 28(3):100036. PubMed ID: 38320382
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Sclerostin and Interleukin 6 Levels and Selected Anthropometric Parameters in Patients Receiving Hemodialysis Replacement Therapy-Pilot Study.
Turon-Skrzypinska A; Dutkiewicz G; Marchelek-Mysliwiec M; Dziedziejko V; Ciechanowski K; Ryl A; Rotter I
Medicina (Kaunas); 2019 Dec; 55(12):. PubMed ID: 31847451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
